4.6 Article

Long-Term Follow-Up After Fractional Flow Reserve-Guided Treatment Strategy in Patients With an Isolated Proximal Left Anterior Descending Coronary Aden, Stenosis

Journal

JACC-CARDIOVASCULAR INTERVENTIONS
Volume 4, Issue 11, Pages 1175-1182

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2011.09.007

Keywords

fractional flow reserve; proximal left anterior descending coronary artery; myocardial ischemia

Funding

  1. Meijer Lavino Foundation for Cardiac Research

Ask authors/readers for more resources

Objectives This study sought to evaluate the long-term clinical outcome of patients with an angio-graphically intermediate left anterior descending coronary artery (LAD) stenosis in whom the revascularization strategy was based on fractional flow reserve (FFR). Background When revascularization is based mainly on angiographic guidance, a number of hemodynamically nonsignificant stenoses will be revascularized. Methods In 730 patients with a 30% to 70% isolated stenosis in the proximal LAD and no significant valvular disease, FFR measurements were obtained to guide treatment strategy. When FFR was >= 0.80, the patients (n = 564) were treated medically (medical group); when FFR was < 0.80, the patients (n = 166) underwent a revascularization procedure (revascularization group; 13% coronary artery bypass graft surgery and 87% percutaneous coronary intervention). A 100% long-term clinical follow-up (median follow-up: 40 months) was obtained. The 5-year survival of the medical group was compared with that of a reference population. For each patient, 4 controls were selected from an age- and sex-matched control population. Results The 5-year survival estimate was 92.9% in the medical group versus 89.6% in the controls (p = 0.74). The mean diameter stenosis was significantly smaller in the medical than in the revascularization group (39 +/- 14% vs. 54 +/- 13%, p < 0.0001), but there was a large overlap between both groups. The 5-year event-free survival estimates (death, myocardial infarction, and target vessel revascularization) were 89.7% and 68.5%, respectively (p < 0.0001). Conclusions Medical treatment of patients with a hemodynamically nonsignificant stenosis (FFR >= 0.80) in the proximal LAD is associated with an excellent long-term clinical outcome with survival at 5 years similar to an age- and sex-matched control population. (J Am Coll Cardiol Intv 2011;4: 1175-82) (C) 2011 by the American College of Cardiology Foundation

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Cardiac & Cardiovascular Systems

Consultation in the CardioVerse : The doctor will see your avatar now

Ioannis Skalidis, Stephane Fournier, Nathalie Noirclerc, Olivier Muller, Emmanouil Skalidis, Niccolo Maurizi

TRENDS IN CARDIOVASCULAR MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Diagnostic performance of angiography-derived fractional flow reserve in patients with NSTEMI

Ioannis Skalidis, David Meier, Bernard De Bruyne, Carlos Collet, Jeroen Sonck, Thabo Mahendiran, David Rotzinger, Salah Dine Qanadli, Eric Eeckhout, Olivier Muller, Stephane Fournier

Summary: Noninvasive methods of estimating invasively measured fractional flow reserve (FFRinvasive) are actively being explored, aiming to avoid invasive procedures and drugs. This study evaluates the diagnostic performance of coronary angiography-derived FFR (FFRangio) in NSTEMI patients, demonstrating its sensitivity, specificity, and accuracy. FFRangio can precisely estimate FFRinvasive in NSTEMI patients and guide treatment decisions for coronary artery lesions without invasive procedures or drugs.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2023)

Article Cardiac & Cardiovascular Systems

Comparison of the prognostic value of impaired stress myocardial blood flow, myocardial flow reserve, and myocardial flow capacity on low-dose Rubidium-82 SiPM PET/CT

Matthieu Dietz, Christel H. Kamani, Gilles Allenbach, Vladimir Rubimbura, Stephane Fournier, Vincent Dunet, Giorgio Treglia, Marie Nicod Lalonde, Niklaus Schaefer, Eric Eeckhout, Olivier Muller, John O. Prior

Summary: Using low-dose silicon photomultipliers (SiPM) technology with Rb-82 cardiac PET/CT, impaired global stress MBF, global MFR, and regional MFC were found to be powerful predictors of major adverse cardiovascular events (MACE), outperforming traditional risk factors. However, only reduced global stress MBF independently predicted MACE.

JOURNAL OF NUCLEAR CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Combining European and US risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study

Roxane de La Harpe, Christian W. Thorball, Claire Redin, Stephane Fournier, Olivier Mueller, Davide Strambo, Patrik Michel, Peter Vollenweider, Pedro Marques-Vidal, Jacques Fellay, Julien Vaucher

Summary: This study aimed to determine whether using polygenic risk scores improves the prediction of atherosclerotic cardiovascular disease risk when combined with clinical scores. The results showed that combining a polygenic risk score with clinical risk scores significantly improved risk reclassification for patients with intermediate risk for cardiovascular disease.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial

Juan F. Iglesias, Olivier Muller, Sylvain Losdat, Marco Roffi, David J. Kurz, Daniel Weilenmann, Christoph Kaiser, Dik Heg, Stephan Windecker, Thomas Pilgrim

Summary: In a randomized trial, ultrathin-strut biodegradable polymer sirolimus-eluting stents (BP-SES) were found to be superior to thin-strut durable polymer everolimus-eluting stents (DP-EES) in terms of target lesion failure (TLF) at 2 years among patients with ST-segment elevation myocardial infarction (STEMI). The study also revealed that regardless of whether patients underwent complex or noncomplex primary percutaneous coronary intervention (pPCI), BP-SES were superior to DP-EES.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2023)

Article Cardiac & Cardiovascular Systems

Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis

Marco Durig, Diego Arroyo, Marc Bedossa, Philippe Commeau, Stephane Fournier, Olivier Mueller, Paul Barragan, Herve Le Breton, Serban Puricel, Stephane Cook

Summary: This study provides data on patients presenting with acute coronary syndrome due to unprotected left main coronary artery (ULMCA) occlusion. The study found that ULMCA occlusion has a high short-term mortality rate, with 15% of patients dying in the cath lab and 42% dying in hospital. Patients who survived the index hospitalization had similar mortality rates as other st elevation myocardial infarction patients.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2023)

Article Endocrinology & Metabolism

Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality

Chor-Wing Sing, Tzu-Chieh Lin, Sharon Bartholomew, J. Simon Bell, Corina Bennett, Kebede Beyene, Pauline Bosco-Levy, Brian D. Bradbury, Amy Hai Yan Chan, Manju Chandran, Cyrus Cooper, Maria de Ridder, Caroline Y. Doyon, Cecile Droz-Perroteau, Ganga Ganesan, Sirpa Hartikainen, Jenni Ilomaki, Han Eol Jeong, Douglas P. Kiel, Kiyoshi Kubota, Edward Chia-Cheng Lai, Jeff L. Lange, E. Michael Lewiecki, Julian Lin, Jiannong Liu, Joe Maskell, Mirhelen Mendes de Abreu, James O'Kelly, Nobuhiro Ooba, Alma B. Pedersen, Albert Prats-Uribe, Daniel Prieto-Alhambra, Simon Xiwen Qin, Ju-Young Shin, Henrik T. Sorensen, Kelvin Bryan Tan, Tracy Thomas, Anna-Maija Tolppanen, Katia M. C. Verhamme, Grace Hsin-Min Wang, Sawaeng Watcharathanakij, Stephen J. Wood, Ching-Lung Cheung, Ian C. K. Wong

Summary: In this international study, the researchers analyzed the incidence of hip fractures, post-fracture treatment, and all-cause mortality following hip fractures across different countries and regions. They used patient-level healthcare data from 19 countries and identified 4,115,046 hip fractures from 2005 to 2018. The study revealed variations in the global epidemiology of hip fractures and post-fracture outcomes, highlighting the need for interventions to reduce the burden of osteoporotic fractures.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Editorial Material Cardiac & Cardiovascular Systems

The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation

Farhang Aminfar, Vladimir Rubimbura, Luc Maillard, Stephane Noble, Gregoire Range, Loic Belle, Francois Derimay, Anne Bellemain-Appaix, Alexis Al Karaky, Jean-Francois Morelle, Georgios Sideris, Pascal Motreff, Olivier Muller, Julien Adjedj

EUROINTERVENTION (2023)

Article Pharmacology & Pharmacy

Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study

Aniek F. Markus, Victoria Y. Strauss, Edward Burn, Xintong Li, Antonella Delmestri, Christian Reich, Can Yin, Miguel A. Mayer, Juan-Manuel Ramirez-Anguita, Edelmira Marti, Katia M. C. Verhamme, Peter R. Rijnbeek, Daniel Prieto-Alhambra, Annika M. Joedicke

Summary: This study aimed to characterize the treatment of Thrombosis with thrombocytopenia syndrome (TTS) and other thromboembolic events after COVID-19 vaccination and compare them with pre-vaccination data. The results showed significant variability in the proportion of people treated across different databases before and after vaccination.

FRONTIERS IN PHARMACOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset

Miklos Rohla, Fabrice Temperli, George C. M. Siontis, Roland Klingenberg, Baris Gencer, Nicolas Rodondi, Sarah Bar, David Nanchen, Francois Mach, Jonas D. Haner, Thomas Pilgrim, Olivier Muller, Christian M. Matter, Thomas Luscher, Marco Roffi, Dik Heg, Stephan Windecker, Lorenz Raber

Summary: This study compared the outcomes of STEMI patients undergoing PCI according to total ischemic time. The results showed that PCI performed within 12 hours of symptom onset had better outcomes, while PCI performed later than 12 hours was associated with higher mortality and target lesion failure rates. However, there was no significant difference in outcomes between PCI performed later than 48 hours and PCI performed between 12-48 hours.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Cardiac & Cardiovascular Systems

Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries

Mattia Lunardi, Mamas A. Mamas, Josepa Mauri, Carmen Medina Molina, Oriol Rodriguez-Leor, Simon Eggington, Jan B. Pietzsch, Natalie L. Papo, Silke Walleser-Autiero, Andreas Baumbach, Francesco Maisano, Flavio L. Ribichini, Darren Mylotte, Emanuele Barbato, Jan J. Piek, William Wijns, Christoph K. Naber

Summary: The untimely or missed revascularization of STEMI patients during the COVID-19 pandemic has led to increased morbidity, mortality, and long-term adverse health outcomes. The analysis shows that the reduced treatment during lockdown led to a significant loss in survival and quality-adjusted life-years, as well as increased costs at the population level. The findings highlight the importance of timely revascularization and the potential long-term implications of delayed treatment for STEMI patients during a pandemic.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Cardiac & Cardiovascular Systems

Validation of a multiple-lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy

Niccolo Maurizi, Carlo Fumagalli, Ioannis Skalidis, Jacopo F. Imberti, Alessandro Faragli, Mattia Targetti, Henri Lu, Pierre Monney, Olivier Muller, Niccolo Marchionni, Franco Cecchi, Iacopo Olivotto

Summary: This study validated the accuracy of the D-Heart ECG device, a smartphone 8/12-Lead electrocardiograph with an image processing algorithm, for diagnosing ECG abnormalities in patients with hypertrophic cardiomyopathy. The results showed that the D-Heart ECG device had high accuracy and concordance with standard 12-Lead ECG, and the image processing algorithm provided accurate electrode placement, standardizing the quality of the examination.

JOURNAL OF ELECTROCARDIOLOGY (2023)

Article Endocrinology & Metabolism

Drug utilization analysis of osteoporosis medications in seven European electronic health databases

Eng Hooi Tan, Danielle E. E. Robinson, Annika M. M. Joedicke, Mees Mosseveld, Katrine Bodkergaard, Carlen Reyes, Alireza Moayyeri, Annemarie Voss, Ettore Marconi, Francesco Lapi, Jonas Reinold, Katia M. C. Verhamme, Lars Pedersen, Malte Braitmaier, Marcel de Wilde, Marc Far Ruiz, Maria Aragon, Pauline Bosco-Levy, Regis Lassalle, Daniel Prieto-Alhambra, Maria T. T. Sanchez-Santos

Summary: The study examined patients prescribed osteoporosis medication and their usage patterns in European databases. Female, older patients with hypertension were the most common. Low persistence rates were observed for oral medications. These findings are important for healthcare providers to improve patient persistence with specific osteoporosis treatments.

OSTEOPOROSIS INTERNATIONAL (2023)

Article Public, Environmental & Occupational Health

IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model

Berta Raventos, Marti Catala, Mike Du, Yuchen Guo, Adam Black, Ger Inberg, Xintong Li, Kim Lopez-Guell, Danielle Newby, Maria de Ridder, Cesar Barboza, Talita Duarte-Salles, Katia Verhamme, Peter Rijnbeek, Daniel Prieto Alhambra, Edward Burn

Summary: The study developed an R package for calculating incidence rates and prevalence in OMOP CDM data, which was validated by comparing with published data and running benchmark analysis. The package can support descriptive epidemiological research and provide reliable estimations from large real-world datasets.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023)

Review Respiratory System

Methods to assess COPD medications adherence in healthcare databases: a systematic review

Delphine Vauterin, Frauke Van Vaerenbergh, Anna Vanoverschelde, Jennifer K. Quint, Katia Verhamme, Lies Lahousse

Summary: This article systematically reviews the existing methods for assessing adherence to COPD medication in healthcare databases and evaluates the reporting of influencing variables. The study finds significant variations in adherence assessment methods and recommends attention to transparency and reporting of variables.

EUROPEAN RESPIRATORY REVIEW (2023)

No Data Available